TriangleQuestions to ask before joining a cancer clinical trial
Consent is a conversation, not a signature. These are the questions that conversation is supposed to answer, and where the answers usually live.
This is not clinical evidence and not medical advice. It does not replace your care team. Discuss anything here with your clinician before you act on it. Product questions are on the FAQ.
The usual path: a short pre-screen to see whether you might fit, a longer consent conversation, then a fuller look at your history and tests before anything starts. You can ask questions at every step. You can stop at any of them. I keep the NCT number at the top of my notes so we are talking about the same study.
Am I eligible, and what would rule me out?
Every trial has criteria covering diagnosis, prior treatment, age, sometimes tumour genetics. Ask the coordinator which lines are the tight ones for you.
What will I actually be asked to do?
The consent form should describe the purpose, the tests and procedures, the drugs, how many people are in each group, and how long it runs. Ask which visits and tests are extra compared with your usual care.
Placebo, randomization, cost
Placebos are rare in cancer treatment trials and they are never hidden: if one is used, it is in the consent form. In a randomized study, neither you nor your doctor chooses your group. Ask which of those applies.
Costs come in two piles. Patient-care costs — visits and standard treatment you would have anyway — are often covered by insurance. Research costs — the study drug, tests done only for the trial — are often not covered by insurance, and are often paid by the sponsor. Ask the coordinator to walk through both lists, and ask whether the study helps with travel or lodging.
Can I leave, and who is watching?
Yes, you can leave. Taking part is voluntary. Signing the form does not bind you. Ask what happens to your care if you stop, and how your regular oncologist is kept informed while you are enrolled.
An institutional review board reviews the protocol before a study opens and at least yearly after that, and can change or stop it. Some trials, especially Phase 3, also have an independent data and safety monitoring board. Ask who to call if something feels wrong between visits.
You do not need a referral. Your doctor can help you find a study that fits, but you can contact a study team yourself from the ClinicalTrials.gov record.
See recruiting Phase 1 trials →
Sources
- NCI: What to Expect During a Clinical TrialJoining a trial follows pre-screening, informed consent, and screening steps before participation begins.
- NCI: How Do Clinical Trials Work?Eligibility criteria commonly cover health, medical and treatment history, age, and tumour genetic changes.
- NCI: Understanding Cancer Research Consent FormsThe consent form describes purpose, procedures, drugs, group sizes, and study length; taking part is voluntary and you may leave at any time; signing does not bind you to the study.
- NCI: How Do Clinical Trials Work?Placebos are rarely used in cancer treatment trials, are disclosed in the consent form, and in randomized trials neither you nor your doctor picks your group.
- NCI: Who Pays for Clinical Trials?Patient care costs are often covered by insurance; research costs are often not covered by insurance but may be covered by the sponsor; some trials help with travel costs.
- NCI: Are Clinical Trials Safe?IRBs review protocols before enrolment and yearly, and can change or stop a trial; some trials, especially Phase 3, use a data and safety monitoring board.
- NCI: Facts About Clinical TrialsYou do not need a referral from your doctor to take part in a clinical trial; you can often keep seeing your current care team.